Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.

Authors: Bukhari, I A; Alorainey, B I; Al-Motrefi, A A; Mahmoud, A; Campbell, W B; Hammock, B D

Published In Eur Rev Med Pharmacol Sci, (2020 08)

Abstract: OBJECTIVE: This study evaluated the efficacy of the soluble epoxide hydrolase (sEH) inhibitor, TPPU on chronic NG-Nitro L-arginine methyl ester (L-NAME)-induced hypertension in rats and its effects on plasma Angiotensin II (Ang II), cardiac Angiotensin-converting enzyme (ACE) and Angiotensin II receptor type 1 (AT1R) expressions. MATERIALS AND METHODS: Forty Sprague Dawley rats were divided into 5 groups. Two groups served as control and received orally either vehicle or TPPU (3 mg/kg) for five weeks. The other three groups were given L-NAME (50 mg/kg/day) in drinking water for five weeks. Two weeks after the L-NAME treatment, animals received orally either saline or TPPU (3 mg/kg/day) or lisinopril (10 mg/kg/day) daily for 3 weeks. Blood pressure (BP) was measured weekly. At the end of the experiment, plasma Ang II, cardiac ACE and AT1R protein and gene expressions were determined. RESULTS: L-NAME caused a significant increase in BP of the animals. TPPU and lisinopril resulted in normalization of L-NAME-induced hypertension. They also caused a significant reduction in Ang II and ACE protein and gene expressions compared to L-NAME and vehicle-treated animals. CONCLUSIONS: This study demonstrates that TPPU effectively lowers L-NAME-induced hypertension in rats. The mechanism of its antihypertensive effect is likely mediated by the suppression of ACE gene and protein expression, leading to a lower Ang II level.

PubMed ID: 32767352 Exiting the NIEHS site

MeSH Terms: Angiotensin II/metabolism; Angiotensin Receptor Antagonists/pharmacology*; Angiotensin-Converting Enzyme 2/antagonists & inhibitors*; Angiotensin-Converting Enzyme 2/metabolism; Angiotensin-Converting Enzyme Inhibitors/pharmacology*; Animals; Epoxide Hydrolases/antagonists & inhibitors*; Epoxide Hydrolases/metabolism; Hypertension/chemically induced; Hypertension/drug therapy*; Male; NG-Nitroarginine Methyl Ester; Phenylurea Compounds/pharmacology*; Piperidines/pharmacology*; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1/metabolism

to Top